These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 17404538)

  • 1. [Second-line treatment of non-small-cell lung cancers].
    Moro-Sibilot D
    Rev Pneumol Clin; 2006 Dec; 62(6 Pt 2):2S37-40. PubMed ID: 17404538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-small cell lung cancer - from treatment of relapse to treatments for relapses].
    Souquet PJ
    Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S108-13. PubMed ID: 18235402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second and third line treatment in non-small cell lung cancer.
    Favaretto A; Pasello G; Magro C; Schettino C; Gridelli C
    Crit Rev Oncol Hematol; 2009 Aug; 71(2):117-26. PubMed ID: 19249227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-line chemotherapy for non-small-cell lung cancer: is there a superior regimen based on histology?
    Einhorn LH
    J Clin Oncol; 2008 Jul; 26(21):3485-6. PubMed ID: 18506022
    [No Abstract]   [Full Text] [Related]  

  • 5. Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer.
    Di Maio M; Chiodini P; Georgoulias V; Hatzidaki D; Takeda K; Wachters FM; Gebbia V; Smit EF; Morabito A; Gallo C; Perrone F; Gridelli C
    J Clin Oncol; 2009 Apr; 27(11):1836-43. PubMed ID: 19273711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Second line chemotherapy in metastatic non-small cell lung cancer].
    Moro-Sibilot D; Coudurier M
    Rev Prat; 2009 Sep; 59(7):952-3. PubMed ID: 19839464
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiangiogenic metronomic chemotherapy.
    Sarmiento R; Gasparini G
    Onkologie; 2008 Apr; 31(4):161-2. PubMed ID: 18418015
    [No Abstract]   [Full Text] [Related]  

  • 8. Typhlitis during second-line chemotherapy with pemetrexed in non-small cell lung cancer (NSCLC): A case report.
    Tiseo M; Gelsomino F; Bartolotti M; Barili MP; Ardizzoni A
    Lung Cancer; 2009 Aug; 65(2):251-3. PubMed ID: 19346026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemetrexed for the treatment of non-small-cell lung cancer.
    Manegold C; Schmid-Bindert G; Pilz LR
    Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multimodal therapy of small cell and non-small cell lung carcinoma].
    Serke M; Kollmeier J
    Dtsch Med Wochenschr; 2007 Jun; 132(22):1221-4. PubMed ID: 17520508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer.
    Engelman JA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4637-40. PubMed ID: 17671156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
    Sangha R; Lara PN; Mack P; Gandara DR
    Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
    [No Abstract]   [Full Text] [Related]  

  • 13. Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancer.
    Gridelli C
    Curr Opin Oncol; 2009 Mar; 21(2):97-8. PubMed ID: 19532008
    [No Abstract]   [Full Text] [Related]  

  • 14. Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
    Azzoli CG; Kris MG; Pfister DG
    J Natl Cancer Inst; 2007 Jun; 99(11):828-9. PubMed ID: 17551137
    [No Abstract]   [Full Text] [Related]  

  • 15. A potential agent for treating non-small cell lung cancer.
    Ou JS; Huang DD; Ou ZJ
    Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):985-6. PubMed ID: 18782201
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy for advanced stage non-small cell lung cancer.
    Fathi AT; Brahmer JR
    Semin Thorac Cardiovasc Surg; 2008; 20(3):210-6. PubMed ID: 19038730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
    Bunn PA; Thatcher N
    Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twisted tail: spinal epidural lipomatosis responding to chemotherapy in a patient with non-small-cell lung cancer.
    Nasoodi A; McAleese J; Grey A; Stranex S
    J Med Imaging Radiat Oncol; 2008 Oct; 52(5):525-6. PubMed ID: 19032401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy.
    Bearz A; Serraino D; Fratino L; Berretta M; Tirelli U
    Cancer; 2007 Dec; 110(11):2593-4; author reply 2594. PubMed ID: 17960771
    [No Abstract]   [Full Text] [Related]  

  • 20. Foreword; challenging the 'one-size-fits-all' approach of chemotherapy and radiotherapy for patients with non-small cell lung cancer.
    Kris MG
    Lung Cancer; 2008 Jun; 60 Suppl 2():S1-2. PubMed ID: 18513578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.